← Evidence map

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer.

Tatsuya Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

148 papers cite itlatest 60 shown

2016
…
2019
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27354483